Bemotrizinol

The U.S. FDA approved bemotrizinol, a sunscreen ingredient used in Europe and Asia for decades, as the first new over-the-counter sunscreen ingredient in the U.S. since 1999. The approval, effective June 9, 2026, highlights a long-awaited addition to U.S. sun protection options.

The FDA has approved bemotrizinol (BEMT), a new active ingredient for over-the-counter sunscreens, marking the first approval in over 25 years. BEMT has been used in Europe and Asia since the 1990s. Dermatologist Dr. Rachel Nazarian discussed the significance of this change with Amna Nawaz.

The FDA approved the first new sunscreen filter in 27 years, bemotrizinol (sold as PARSOL®), ending a long dry spell. While new to the U.S., the ingredient is already used internationally.

The FDA approved bemotrizinol, the first new sunscreen filter in over two decades, ending a 27-year dry spell. While new to the U.S., the ingredient is already established internationally under the brand name PARSOL®.

The FDA approved a new sunscreen ingredient called Bemotrizinol. The article outlines four key points about this ingredient and its implications for skin protection.

The FDA approved Bemotrizinol, the first new sunscreen ingredient in over 25 years, offering enhanced protection against UVA rays. This approval marks a significant update to sunscreen formulations, which had not seen new active ingredients since the 1990s.

The FDA has approved bemotrizinol, a sunscreen ingredient used abroad for decades, for use in the U.S. after it met safety and effectiveness standards. The ingredient will initially be sold as Parsol Shield by DSM Nutritional Products, with other manufacturers allowed to use it after an 18-month exclusivity period.

The FDA has approved bemotrizinol, a sunscreen ingredient previously used in Europe, offering enhanced protection against UVB and UVA rays. Dr. Adam Friedman, a dermatologist at George Washington University, highlights its photostability, potential to improve existing sunscreens, and public health benefits in preventing skin aging and cancer.

The FDA approved Bemotrizinol, a sunscreen ingredient previously used in Europe and Asia, for use in the U.S. The chemical compound provides protection against UVA and UVB rays.

The FDA approved bemotrizinol, a sunscreen ingredient, marking the first new sunscreen ingredient authorization in over 25 years. CBS News medical correspondent Dr. Céline Gounder reported on the development.

The FDA approved Bemotrizinol, a sunscreen ingredient used safely in Europe for decades, to enhance sunscreen effectiveness and consumer confidence. The approval follows a 20-year review and addresses concerns about ingredient safety and product formulation, with industry and advocacy groups supporting its introduction to the U.S. market.

The FDA is approving Bemotrizinol, its first new sunscreen ingredient in over 20 years, which blocks both UVA and UVB rays and is cleared for use by adults and children 6 months and older. The ingredient has been available in Europe and is now being recognized for broader use in the U.S.

The FDA approved bemotrizinol, a UVA/UVB-blocking sunscreen ingredient popular in Europe and Asia, marking the first new sunscreen ingredient approved in the U.S. since 1999. This update addresses U.S. sunscreen's historical lag in effectiveness and smooth application, though new products will take over a year to reach consumers.

The FDA approved bemotrizinol as a new active ingredient in sunscreen, marking the first addition to the list of permitted ingredients since the late 1990s.

The FDA has approved bemotrizinol, a new sunscreen ingredient, after over 20 years of regulatory delays. Dermatologists and skincare enthusiasts are excited about its enhanced protection.

The FDA approved bemotrizinol, a sunscreen ingredient previously used in Europe, as the first new U.S. sunscreen ingredient in over 25 years. The agency confirmed it meets safety standards for UV protection with minimal skin irritation or absorption, suitable for adults and children 6 months and older.

The FDA approved bemotrizinol, the first new sunscreen ingredient in over 25 years, which protects against both UVA and UVB rays without leaving white streaks. It will initially be sold by DSM Nutritional Products under the brand Parsol Shield and becomes available to other manufacturers after an 18-month exclusivity period.

The FDA has approved Bemotrizinol, a UV light filter that has been available in Europe, Australia, and some Asian countries. The ingredient is now permitted for use in the United States.